DEFA14A ·Filed Apr 27, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Routine proxy supplement; no immediate trading implications. Monitor for definitive proxy statement or shareholder meeting results.
Final — all horizons settled through T+60d
QNCX ▼ -25.69% at T+60d
NEUTRAL call ✗ call lost -25.69% · α vs SPY -29.68% · entry $24.60 → $18.28
T+1d
0.00%
call 0.00% · α +0.02%
$24.60
settled 5mo ago
T+5d
0.00%
call 0.00% · α -1.70%
$24.60
settled 5mo ago
T+20d
-6.50%
call -6.50% · α -11.95%
$23.00
settled 4mo ago
T+60d
-25.69%
call -25.69% · α -29.68%
$18.28
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Quince Therapeutics filed DEFA14A supplemental proxy materials, likely to provide additional information for the upcoming annual meeting. The filing is routine and contains no financial data or material events.
Key Facts
- DEFA14A filed on April 27, 2026, as additional definitive proxy soliciting material.
- Cross-filing context includes an 8-K from April 22, 2026, appointing June Bray to the board of directors.
Financial Impact
Not specified
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-182267 |
| Document: 0001193125-26-182267-index-headers.html | 0001193125-26-182267 |
| Document: 0001193125-26-182267-index.html | 0001193125-26-182267 |
| Document: 0001193125-26-182267.txt | 0001193125-26-182267 |
9 reports for QNCX
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | 8-K | $31.32 $28.59 | ▲ +8.72% | ▲ +7.51% | $30.20 (+3.58%) |
Aug 25, 2026 5w ago | EFFECT | $30.93 $32.11 | ▼ −3.82% | ▼ −4.35% | $30.20 (+2.36%) |
Aug 14, 2026 7w ago | 8-K | $31.34 awaiting T+5 | awaiting T+5 | — | $30.20 (−3.64%) |
Aug 14, 2026 7w ago | Press Release | $31.34 awaiting T+5 | awaiting T+5 | — | $30.20 (−3.64%) |
Aug 5, 2026 8w ago | S-3/A | $28.88 $31.26 | ▲ +8.24% | ▲ +7.89% | $30.20 (+4.57%) |
Jun 11, 2026 16w ago | 3 | $0.9337 $0.9451 | ▲ +1.22% | ▲ +0.55% | $30.20 (+3134.44%) |
May 18, 2026 19w ago | 8-K | $19.90 $24.00 | ▲ +20.60% | ▲ +18.99% | $30.20 (+51.76%) |
Apr 27, 2026 22w ago | DEFA14A | $24.60 $24.60 | · 0.00% | ▼ −1.70% | $30.20 (+22.76%) |
Apr 9, 2026 25w ago | 8-K | $1.24 $1.34 | ▲ +8.06% | ▲ +4.88% | $30.20 (+2335.48%) |
Showing 9 of 9
US Market Status
Market Open — Closes in 3h 40m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access